CYP2C93 variant is associated with antidiabetes efficacy of gliclazide in Chinese type 2 diabetes patients
This study demonstrated that polymorphism at rs1057910 significantly affected therapeutic response of gliclazide in type 2 diabetes mellitus patients. It associated with the decrease of FPG and the rate of treatment success in the gliclazide monotherapy.
Bibliographic Details
| Main Authors: |
Zeng, Wotan,
Guo, Yali,
Chen, Peixian,
Liu, Zhike,
Chen, Dafang,
Han, Chunji |
|---|
| Format: | Online
|
|---|
| Language: | English |
|---|
| Published: |
John Wiley and Sons Inc.
2016
|
|---|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009140/
|
|---|